Rhoen Klinikum AG (STU:RHK) E10: €0.53 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:RHK Rhoen Klinikum AG STU:RHK
77 GF Score
Price €14.30
GF Value €13.80
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG E10?

Rhoen Klinikum AG STU:RHK 77 E10 is €0.53 as of Jun. 2026. GuruFocus rates STU:RHK with a GF Score™ of 77/100 and a GF Value™ of €13.80 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rhoen Klinikum AG's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.135. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.53 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Rhoen Klinikum AG's average E10 Growth Rate was -19.40% per year. During the past 3 years, the average E10 Growth Rate was -29.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Rhoen Klinikum AG was 0.20% per year. The lowest was -29.00% per year. And the median was -13.35% per year.

As of today (2026-09-17), Rhoen Klinikum AG's current stock price is €14.30. Rhoen Klinikum AG's E10 for the quarter that ended in Jun. 2026 was €0.53. Rhoen Klinikum AG's Shiller PE Ratio of today is 27.24.

During the past 13 years, the highest Shiller PE Ratio of Rhoen Klinikum AG was 27.78. The lowest was 5.22. And the median was 12.16.


Rhoen Klinikum AG  (STU:RHK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rhoen Klinikum AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=14.30/0.525
=27.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Rhoen Klinikum AG was 27.78. The lowest was 5.22. And the median was 12.16.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rhoen Klinikum AG E10 Related Terms


Rhoen Klinikum AG E10 Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG E10 Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.65 1.74 1.79 0.71 0.62

Rhoen Klinikum AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.64 0.62 0.55 0.53

STU:RHK vs HCA, THC, EHC: E10 Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Shiller PE Ratio falls into.


STU:RHK
77GF Score
Rhoen Klinikum AG STU:RHK
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rhoen Klinikum AG's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.135/131.3638*131.3638
=0.135

Current CPI (Jun. 2026) = 131.3638.

Rhoen Klinikum AG Quarterly Data

per share eps CPI Adj_EPS
201609 0.180 101.017 0.234
201612 -0.360 101.217 -0.467
201703 0.120 101.417 0.155
201706 0.120 102.117 0.154
201709 0.140 102.717 0.179
201712 0.140 102.617 0.179
201803 0.150 102.917 0.191
201806 0.100 104.017 0.126
201809 0.428 104.718 0.537
201812 0.050 104.217 0.064
201903 0.124 104.217 0.157
201906 0.172 105.718 0.214
201909 0.255 106.018 0.315
201912 0.096 105.818 0.119
202003 -0.066 105.718 -0.083
202006 0.003 106.618 0.004
202009 0.086 105.818 0.107
202012 -0.001 105.518 -0.001
202103 0.017 107.518 0.020
202106 0.104 108.486 0.126
202109 0.099 109.435 0.119
202112 0.203 110.384 0.242
202203 0.015 113.968 0.017
202206 0.157 115.760 0.178
202209 0.073 118.818 0.080
202212 0.131 119.345 0.144
202303 0.094 122.402 0.100
202306 0.086 123.140 0.091
202309 0.167 124.195 0.177
202312 0.232 123.773 0.247
202403 0.161 125.038 0.169
202406 0.135 125.882 0.141
202409 0.142 126.198 0.148
202412 0.210 127.041 0.217
202503 0.107 127.779 0.110
202506 0.105 128.412 0.107
202509 0.148 129.255 0.151
202512 0.155 129.361 0.158
202603 0.190 131.258 0.190
202606 0.135 131.364 0.135

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.53 mean?
Rhoen Klinikum AG (STU:RHK) has a E10 of €0.53 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Rhoen Klinikum AG and its competitors.
Is Rhoen Klinikum AG's E10 too high?
Rhoen Klinikum AG's current E10 is €0.53. Overall, Rhoen Klinikum AG has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's E10 compare to HCA and THC?
Rhoen Klinikum AG's E10 of €0.53 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current E10 is €0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Based on GuruFocus' analysis, Rhoen Klinikum AG (STU:RHK) is currently considered Fairly Valued. The stock's GF Value™ is €13.80, compared to a current price of €14.30 — trading 3.6% above its estimated fair value. The current E10 is €0.53. Rhoen Klinikum AG's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Rhoen Klinikum AG (STU:RHK), the current E10 is €0.53 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (STU:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.30 is trading 3.6% above its estimated GF Value™ of €13.80. GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.

Key valuation signals for STU:RHK:

  • E10: €0.53
  • GF Value™: €13.80 vs. price of €14.30 (3.6% above fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the STU:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UK
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
77GF Score

Get the complete analysis for STU:RHK

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.30
Price
€13.80
GF Value